SCHEMBL723388

SCHEMBL723388

c1ccc(-c2ccnc3cc(-c4ccc(N5CCOCC5)cc4)oc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.51
MAPT P10636 4/20 0.51
ALDH1A1 P00352 4/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
HPGD P15428 1/20 0.51
MAPK1 P28482 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
PRKDC P78527 6/20 0.50
ACVR1B P36896 2/20 0.47
TGFBR1 P36897 2/20 0.47
BMPR1B O00238 1/20 0.47
PDGFRB P09619 1/20 0.47
KIT P10721 1/20 0.47
PDGFRA P16234 1/20 0.47
BMPR1A P36894 1/20 0.47
ACVRL1 P37023 1/20 0.47
ACVR1 Q04771 1/20 0.47
LMNA P02545 3/20 0.46
PDE4A P27815 1/20 0.46
KDR P35968 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL722381 0.89 PRKDC (0.47) PRKDCACVR1BTGFBR1BMPR1BPDGFRB
SCHEMBL724726 0.86 CNR2 (0.50) KDM4EALDH1A1HPGDLMNAPIK3CD
SCHEMBL723621 0.83 MAPK10 (0.51) ACVR1BTGFBR1BMPR1BBMPR1AACVRL1
SCHEMBL27920129 0.83 CYP1A1 (0.48) KDM4EMAPTALDH1A1HPGDMAPK1
SCHEMBL722890 0.81 PRKDC (0.48) KDM4EMAPTALDH1A1PRKDCACVR1B
SCHEMBL723929 0.78 PIM1 (0.50) KDM4EALDH1A1ACVR1BTGFBR1BMPR1B
SCHEMBL724754 0.77 CNR2 (0.47) PRKDCPIK3CAPIK3CBPIK3CG
SCHEMBL15173041 0.75 CYP1A1 (0.49) MAPTALDH1A1PRKDCJAK2CYP1A2
SCHEMBL723571 0.75 TAAR1 (0.44) KDM4EALDH1A1HPGDPIK3CASMN1; SMN2
SCHEMBL15209104 0.75 MAPKAPK2 (0.48) ACVR1BTGFBR1BMPR1BBMPR1AACVRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US claimed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US claimed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB KDM4E 1009/4885MAPT 4861/4885ALDH1A1 1457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.